https://www.selleckchem.com/pr....oducts/AZD2281(Olapa
50, p less then .001), psychological well-being (difference 4.34, 95% CI 3.70; 4.98, Cohen's d 0.55, p less then .001) and sleep-related QoL (difference -44.61, 95%CI -47.17; -42.05, Cohen's d -1.44, p less then .001) at week 48 compared to baseline. At week 24 dCBT, compared to SHE, also reduced use of prescription and non-prescription sleep medication up to week 24 (adjusted rate ratio [RR] 0.64, 95% CI 0.42; 0.97, p = .037 and adjusted RR 0.52, 95% CI 0.37; 0.74, p less then .0001, respectively), but not healthcare utilizat
Like
Comment
Share
